Pharmacists' contributions to the management of opioid use disorder
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Paul M. Stranges, Kathleen K. Adams, Anwar Alharir, Lindy G. Burnam, Abigail T. Elmes‐Patel, Sage B. Greenlee, Alexander F. Infante, Angela Kerins, Qing Ma, Lyndsi K. Meyenburg, Cecilia Nyman, Golden L. Peters, Kerry Anne Rambaran, D. Max Smith, David E. Zimmerman |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Embracing Pharmacists' Opportunities to Improve Care for People Living With Substance Use Disorders
por: Kirk E. Evoy, et al.
Publicado: (2026)
por: Kirk E. Evoy, et al.
Publicado: (2026)
Role of the Emergency Medicine Pharmacist in the Management of Boarding Patients: An Opinion of the Emergency Medicine Practice and Research Network of the American College of Clinical Pharmacy Endorsed by the SAEM Academy of Emergency Medicine Pharmacists and the Society of Emergency Medicine Pharmacists
por: Brian W. Gilbert, et al.
Publicado: (2026)
por: Brian W. Gilbert, et al.
Publicado: (2026)
Nationwide evaluation of the clinical impact of acute care adult medicine pharmacists
por: Jennifer A. Szwak, et al.
Publicado: (2024)
por: Jennifer A. Szwak, et al.
Publicado: (2024)
Prevalence and Predictors of Diabetes Distress in Hospitalized Patients: A Pharmacist‐Led Intervention
por: Elizabeth K. Tripp, et al.
Publicado: (2025)
por: Elizabeth K. Tripp, et al.
Publicado: (2025)
Impact of an In‐House Resident Clinical Pharmacist On‐Call Program on Resident Physician Training: A Cross‐Sectional Survey
por: Tracy L. Van, et al.
Publicado: (2026)
por: Tracy L. Van, et al.
Publicado: (2026)
The Clinical Pharmacist as Principal Investigator—2026
por: Dave L. Dixon, et al.
Publicado: (2025)
por: Dave L. Dixon, et al.
Publicado: (2025)
Pharmacists' role in combating medical misinformation
por: Ila M. Harris, et al.
Publicado: (2024)
por: Ila M. Harris, et al.
Publicado: (2024)
Development of the Core Outcome Set for Psychiatric Pharmacists
por: Kristina Reinstatler, et al.
Publicado: (2024)
por: Kristina Reinstatler, et al.
Publicado: (2024)
The Cost Conundrum: Pharmacists at the Crossroads of Evidence and Affordability
por: Dejan Landup, et al.
Publicado: (2026)
por: Dejan Landup, et al.
Publicado: (2026)
Measuring Critical Care Pharmacist Value: A Scoping Review of the Effect of Critical Care Pharmacist Activities on Clinically Relevant Outcomes
por: Devin N. Holden, et al.
Publicado: (2026)
por: Devin N. Holden, et al.
Publicado: (2026)
Redefining opioid stewardship
por: Lucas G. Hill
Publicado: (2025)
por: Lucas G. Hill
Publicado: (2025)
Building a Culture of Stewardship: The Role of Infectious Diseases Pharmacists in Promoting Documentation Across Pharmacy Teams
por: Blain Thayer, et al.
Publicado: (2026)
por: Blain Thayer, et al.
Publicado: (2026)
Evaluation of the Current State of Burnout Among Clinical Pharmacists
por: Sydney A. Kisala, et al.
Publicado: (2025)
por: Sydney A. Kisala, et al.
Publicado: (2025)
Characterizing Stigmatizing and Biased Language in Clinical Pharmacist Documentation
por: Caitlin M. Gordon, et al.
Publicado: (2025)
por: Caitlin M. Gordon, et al.
Publicado: (2025)
Expanding Access to Opioid Use Disorder Treatment: Low‐Threshold Buprenorphine Dispensing via an Interprofessional Mobile Medical Unit in Chicago
por: Abigail T. Elmes‐Patel, et al.
Publicado: (2026)
por: Abigail T. Elmes‐Patel, et al.
Publicado: (2026)
From Pharmacist to Pharma: Advice on Career Pathways in Drug Development
por: William P. Petros, et al.
Publicado: (2025)
por: William P. Petros, et al.
Publicado: (2025)
Outcomes of the Pharmacist and Community Health Worker Heart Healthy Clinic Model
por: Mitchell L. Struewing, et al.
Publicado: (2025)
por: Mitchell L. Struewing, et al.
Publicado: (2025)
A Survey of Veterans Affairs Pharmacists: Naloxone Prescribing and Perceived Barriers
por: Garrett Garver, et al.
Publicado: (2025)
por: Garrett Garver, et al.
Publicado: (2025)
Be a Limitless Pharmacist: Remarks by the 2025 Paul F. Parker Medalist
por: Rita R. Alloway
Publicado: (2025)
por: Rita R. Alloway
Publicado: (2025)
Navigating the Alphabet Soup of Interstitial Lung Diseases (ILD): The Role of Pharmacists
por: Amber Lanae Martirosov, et al.
Publicado: (2025)
por: Amber Lanae Martirosov, et al.
Publicado: (2025)
A Bibliometric Analysis of Pharmacist‐Delivered Care: Global Trends, Outcomes, and Practice Settings (2000–2024)
por: Krisy‐Ann Thornby, et al.
Publicado: (2026)
por: Krisy‐Ann Thornby, et al.
Publicado: (2026)
Addressing Threats to Pharmacist Provision of Mental Health and Substance Use Disorder Services
por: Lisa M. Whittington, et al.
Publicado: (2025)
por: Lisa M. Whittington, et al.
Publicado: (2025)
Preventing Dropped Balls: Pharmacists Can Catch Missed Opportunities in Lipid Management
por: Robert B. Parker
Publicado: (2026)
por: Robert B. Parker
Publicado: (2026)
Bridging the Gap in Antibiotic Stewardship at Hospital Discharge: Evaluating the Impact of Pharmacist Interventions
por: Kimberly Ly, et al.
Publicado: (2025)
por: Kimberly Ly, et al.
Publicado: (2025)
Pharmacists in diabetes management: Enhancing patient care through practice, education, and advocacy
por: Jennifer N. Clements, et al.
Publicado: (2025)
por: Jennifer N. Clements, et al.
Publicado: (2025)
Pharmacists should not be gatekeepers but rather advocates for evidence‐based substance use policies
por: Stuart T. Haines
Publicado: (2025)
por: Stuart T. Haines
Publicado: (2025)
Addressing the Impact of Climate Change on Health Using the Pharmacists' Patient Care Process
por: Natalie A. DiPietro Mager, et al.
Publicado: (2026)
por: Natalie A. DiPietro Mager, et al.
Publicado: (2026)
Patients' Perceptions of Pharmacist Prescribing for Minor Ailments and Contraception in British Columbia, Canada
por: Selena Xu, et al.
Publicado: (2026)
por: Selena Xu, et al.
Publicado: (2026)
Comment on “Pharmacists should be held to high standards, not hindered by bright‐line rules”
por: Alex J. Adams
Publicado: (2025)
por: Alex J. Adams
Publicado: (2025)
Pharmacist administered parenteral medications: A descriptive report of an inpatient training program
por: Ryan C. Dillon, et al.
Publicado: (2024)
por: Ryan C. Dillon, et al.
Publicado: (2024)
State of the Union 2026: State‐Level Updates and National Trends in Pharmacist Payment Reform
Publicado: (2026)
Publicado: (2026)
Impact of Home Visits for Hypertension and Dyslipidemia by Community Pharmacists in Thailand: A Randomized Controlled Study
por: Sirin Jeanwiwattanavong, et al.
Publicado: (2026)
por: Sirin Jeanwiwattanavong, et al.
Publicado: (2026)
A Scoping Review of Pharmacist‐Based Interprofessional Interventions for Management of Cardiovascular‐Kidney‐Metabolic Conditions
por: Wendy L. St. Peter, et al.
Publicado: (2026)
por: Wendy L. St. Peter, et al.
Publicado: (2026)
Bridging the Gap: Empowering Pharmacists in Inpatient Injectable Naltrexone and Hospital‐Dispensed Methadone Process Development
por: Yevgeniya Scherbak, et al.
Publicado: (2026)
por: Yevgeniya Scherbak, et al.
Publicado: (2026)
Need for More HIV ‐Trained Pharmacists due to Unmet Needs and Expanding Opportunities: An Opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy
por: Radhika S. Polisetty, et al.
Publicado: (2026)
por: Radhika S. Polisetty, et al.
Publicado: (2026)
Cost‐Utility of Pharmacist‐Led Deprescribing Interventions for Community‐Dwelling Older Adults: A Systematic Review
por: Chiranjeev Sanyal, et al.
Publicado: (2026)
por: Chiranjeev Sanyal, et al.
Publicado: (2026)
Pharmacist certification of drug therapy modification: A survey of pharmacist‐reported practices, facilitators, and barriers in Georgia
por: Rebecca H. Stone, et al.
Publicado: (2024)
por: Rebecca H. Stone, et al.
Publicado: (2024)
A Roadmap for Studying the Impact of Pharmacist Board Certification on Patient Outcomes: Feasibility, Applicability, and Methodological Considerations
por: Robert J. DiDomenico, et al.
Publicado: (2026)
por: Robert J. DiDomenico, et al.
Publicado: (2026)
Impact of Pharmacist‐Led Antimicrobial Stewardship on Antibiotic Use in Intensive Care: A Prospective Audit and Feedback Approach
por: Büşra Ergen, et al.
Publicado: (2026)
por: Büşra Ergen, et al.
Publicado: (2026)
Evaluation of Emergency Medicine Pharmacist Participation in Time to Oral Anticoagulation Reversal: A Systematic Review and Meta‐Analysis
por: Caitlin Brown, et al.
Publicado: (2025)
por: Caitlin Brown, et al.
Publicado: (2025)
Ejemplares similares
-
Embracing Pharmacists' Opportunities to Improve Care for People Living With Substance Use Disorders
por: Kirk E. Evoy, et al.
Publicado: (2026) -
Role of the Emergency Medicine Pharmacist in the Management of Boarding Patients: An Opinion of the Emergency Medicine Practice and Research Network of the American College of Clinical Pharmacy Endorsed by the SAEM Academy of Emergency Medicine Pharmacists and the Society of Emergency Medicine Pharmacists
por: Brian W. Gilbert, et al.
Publicado: (2026) -
Nationwide evaluation of the clinical impact of acute care adult medicine pharmacists
por: Jennifer A. Szwak, et al.
Publicado: (2024) -
Prevalence and Predictors of Diabetes Distress in Hospitalized Patients: A Pharmacist‐Led Intervention
por: Elizabeth K. Tripp, et al.
Publicado: (2025) -
Impact of an In‐House Resident Clinical Pharmacist On‐Call Program on Resident Physician Training: A Cross‐Sectional Survey
por: Tracy L. Van, et al.
Publicado: (2026)